相关实验视频
Updated: Jun 14, 2025

06:00
Fixation and Operational Method for Abdominal Massage in T2DM Mice
Published on: March 7, 2025
164
在怀孕期间使用甲福尔明治疗糖尿病
Christine Newman1, Fidelma P Dunne
1Institute for Clinical Trials, the HRB-Clinical Research Facility, and the College of Medicine, Nursing and Health Sciences, University of Galway, and Galway University Hospital, Galway, Ireland.
Obstetrics and gynecology
|August 29, 2024
概括
甲胺是一种广泛用于妊娠糖尿病的药物,提供了减轻体重增加和胎儿大小等好处. 然而,新生儿面临的潜在风险,例如对妊娠年龄来说很小,需要进行持续的研究.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲福明是治疗2型糖尿病的第一线口服抗高血糖药.
- 自20世纪70年代以来,它一直用于管理妊娠糖尿病 (GDM).
- 怀孕期间肥胖和糖尿病的比例不断上升,凸显出需要有效的干预措施.
研究的目的:
- 审查在怀孕期间使用甲福明的确定的益处和潜在风险.
- 评估甲胺对母亲和胎儿的结果的影响.
- 讨论对临床实践和未来研究的影响.
主要方法:
- 对怀孕中甲福明的现有文献进行系统审查.
- 对报告母亲和新生儿结局的研究分析.
- 对暴露后代的长期随访数据的检查.
主要成果:
- 在怀孕期间使用美特福林与妊娠期体重增加和胎儿大小的减少有关.
- 它可以降低某些患者对胰岛素治疗的需求.
- 有关胎盘转移和孕期新生儿小的潜在风险增加以及后代的更高的BMI z-score存在担忧.
结论:
- 甲胺在治疗妊娠糖尿病方面具有显著的好处,包括成本效益和易用性.
- 对新生儿的潜在风险需要仔细考虑和进一步长期监测.
- 继续进行研究至关重要,以充分了解子宫内暴露于甲胺的儿童的长期健康影响.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
183
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
183
Pathophysiology of Diabetes
908
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
908
Diabetes: Management and Pharmacotherapy
245
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
245
Dipeptidyl Peptidase 4 Inhibitors
178
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
178
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K

